Agents primarily affecting blood constituents or immune system

Sibling codes

• XM0HK5 – Antipsychotics [neuroleptics]
• XM0QJ8 – Neuroprotective agents, not elsewhere classified
• XM0RE9 – Psychostimulants
• XM0YW5 – Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological or dental drugs
• XM16M6 – Other or unspecified drugs, medicaments and biological substances
• XM1950 – Agents primarily acting on smooth and skeletal muscles or the respiratory system
• XM26S4 – Hormones and their synthetic substitutes or antagonists, not elsewhere classified
• XM3973 – Agents primarily affecting the cardiovascular system
• XM3KY1 – Agents affecting genitourinary system, sex or anabolic hormones
• XM3L75 – Sedative hypnotic drugs or other central nervous system depressants
• XM3MU3 – Agents primarily affecting the gastrointestinal system
• XM4G94 – Antidepressants
• XM4TG8 – Agents primarily affecting water and nutrition-balance or metabolism
• XM5MU9 – Systemic antibiotics, anti-infectives or antiparasitics
• XM6CH2 – Drugs primarily affecting the autonomic nervous system
• XM7452 – Antiepileptics or antiparkinsonism drugs
• XM7BA9 – Analgesics, antipyretics or anti-inflammatory drugs
• XM7YD4 – Drugs used in addictive disorders
• XM8014 – Antivertigo and motion sickness preparations
• XM98Y0 – Cannabinoids or hallucinogens
• XM9NV2 – Opioids
• XM9W63 – Agents affecting bones, joints or other connective tissue, not elsewhere classified

Foundation entity

Agents primarily affecting blood constituents or immune system – http://id.who.int/icd/entity/373236638